# Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** FOR-CA-25-086
- **Status:** forecasted
- **Opens:** June 16, 2025
- **CFDA:** 93.395, 93.394
- **View on Kontrakk:** https://kontrakk.com/grants/359726

## Description

No description provided.